Patent expirations have cut into sales at Big Pharma's best in recent quarters. Doom-and-gloom talk over the patent cliff ,and shaky pipelines at pharmaceutical firms, have waxed and waned, but some of the industry's best firms have kept up profitability that would make any Wall Street analyst blush.
Which firms are earning the most for your investment -- and are they really worth your money? Motley Fool contributor Dan Carroll takes a look below at the three firms maintaining the industry's best net profit margins, and explains if these stocks match up to what their businesses are bringing in.
Big Pharma's best stocks can deliver huge rewards to patient investors who can overlook day-to-day moves, and focus on fundamentals and the big picture. Investing for the long term is the one tried-and-true plan that will maximize your portfolio's potential. The Motley Fool's free report,"3 Stocks That Will Help You Retire Rich," not only shares stocks that could help you build long-term wealth, but also winning strategies that every investor should know. Click here to grab your free copy today.
No comments:
Post a Comment